Psoriasis Often Goes Untreated or Undertreated — Physician’s First Watch
Psoriasis Often Goes Untreated or Undertreated
By Kelly Young
Patients with psoriasis are frequently untreated or undertreated, and those who are treated are often dissatisfied with the results, according to a study in JAMA Dermatology.
Some 5600 patients with psoriasis or psoriatic arthritis completed surveys about their treatments between 2003 and 2011. In 2011, 24% of patients with moderate psoriasis and 9% of patients with severe psoriasis (>10% of body surface area) were not being treated. One in three patients with moderate disease and 22% with severe disease received only topical drugs. One of the main reasons was that the providers did not prescribe an alternative.
UV-B was the most commonly used phototherapeutic treatment, and methotrexate was used more often than acitretin or cyclosporine.
Dissatisfaction with treatment was high, with just over half of patients with psoriasis and 46% with psoriatic arthritis reporting they were dissatisfied. Primary reasons for discontinuation of a biologic agent were adverse events and the patient's perception that the drug was not effective.